Discovery & Development

Ensuring that options for patients living with rare diseases aren’t scarce.

US Army combat veteran Luis Alvarez has developed a new drug delivery technology that can convert recombinant proteins into material-binding variants.

New approaches are underway for treating nonalcoholic steatohepatitis.

In this eBook, thought leaders from Cambrex discuss market opportunities, drug development challenges, and more.

Small-molecule Sb9 inhibitor targets both cancer and associated cells to suppress tumor growth in mice.

How can we get macromolecules across the intestinal epithelial barrier?

Vectura has more than 20 years’ experience in helping customers bring inhaled medicines to the market.

Mice with severed spinal cords walk again after gene therapy.

Ewoud van Tricht explores three novel methods that could streamline the development of adenovirus vaccines for COVID-19 at Janssen.

Exploring the role of the gut microbiome on immunotherapy.